Literature DB >> 16250192

Home-based electromyography-triggered stimulation in chronic stroke.

Usama Gabr1, Peter Levine, Stephen J Page.   

Abstract

OBJECTIVES: (1) To determine the feasibility of a home-based electromyography-triggered neuromuscular stimulation (ETMS) programme; and (2) to determine ETMS efficacy in increasing affected wrist extension and reducing affected arm impairment.
DESIGN: Randomized, controlled, pre-post, cross-over design.
SETTING: Outpatient rehabilitation hospital. PATIENTS: Twelve chronic stroke patients with palpable muscle contraction in their affected wrist extensors but no movement (7 males; mean age = 59.75 years, age range 44-75 years; mean time since stroke = 52.75 months, range 13-131 months). INTERVENTION: Subjects were randomly assigned to receive either: (a) ETMS use twice every weekday in 35-min increments during an eight-week period followed by an eight-week home exercise programme (ETMS/home exercise programme) (n=8); or (b) an eight-week home exercise programme followed by use of ETMS twice every weekday in 35-min increments during an eight-week period (home exercise programme) (n=4). MAIN OUTCOME MEASURES: The Fugl-Meyer, Action Research Arm Test and goniometry.
RESULTS: After home exercise programme participation, subjects showed nominal or no changes on any of the outcome measures. After ETMS, patients showed modest impairment reductions, as shown by the Fugl-Meyer, and no Action Research Arm Test changes. However, both groups showed a 21 degree increase in active affected wrist extension after ETMS use.
CONCLUSION: ETMS use is feasible in the home environment. Neither participation in a traditional home exercise programme nor ETMS use conveyed changes on the Fugl-Meyer or Action Research Arm Test. However, ETMS use increased active affected limb extension. This new movement may provide a potential pathway for subjects to participate in other interventions, such as modified constraint induced therapy.

Entities:  

Mesh:

Year:  2005        PMID: 16250192     DOI: 10.1191/0269215505cr909oa

Source DB:  PubMed          Journal:  Clin Rehabil        ISSN: 0269-2155            Impact factor:   3.477


  7 in total

Review 1.  Home-based therapy programmes for upper limb functional recovery following stroke.

Authors:  Fiona Coupar; Alex Pollock; Lynn A Legg; Catherine Sackley; Paulette van Vliet
Journal:  Cochrane Database Syst Rev       Date:  2012-05-16

2.  Neuromuscular Electrical Stimulation for Treatment of Muscle Impairment: Critical Review and Recommendations for Clinical Practice.

Authors:  Ethne L Nussbaum; Pamela Houghton; Joseph Anthony; Sandy Rennie; Barbara L Shay; Alison M Hoens
Journal:  Physiother Can       Date:  2017       Impact factor: 1.037

3.  Mental practice--triggered electrical stimulation in chronic, moderate, upper-extremity hemiparesis after stroke.

Authors:  Stephen J Page; Peter Levine; Valerie Hill
Journal:  Am J Occup Ther       Date:  2015 Jan-Feb

4.  Motor neuroprosthesis for promoting recovery of function after stroke.

Authors:  Luciana A Mendes; Illia Ndf Lima; Tulio Souza; George C do Nascimento; Vanessa R Resqueti; Guilherme Af Fregonezi
Journal:  Cochrane Database Syst Rev       Date:  2020-01-14

Review 5.  What is the evidence for physical therapy poststroke? A systematic review and meta-analysis.

Authors:  Janne Marieke Veerbeek; Erwin van Wegen; Roland van Peppen; Philip Jan van der Wees; Erik Hendriks; Marc Rietberg; Gert Kwakkel
Journal:  PLoS One       Date:  2014-02-04       Impact factor: 3.240

6.  A randomised clinical trial comparing 35 Hz versus 50 Hz frequency stimulation effects on hand motor recovery in older adults after stroke.

Authors:  Trinidad Sentandreu-Mañó; José M Tomás; J Ricardo Salom Terrádez
Journal:  Sci Rep       Date:  2021-04-28       Impact factor: 4.379

7.  A systematic review of measures of adherence to physical exercise recommendations in people with stroke.

Authors:  Tamina Levy; Kate Laver; Maggie Killington; Natasha Lannin; Maria Crotty
Journal:  Clin Rehabil       Date:  2018-11-21       Impact factor: 3.477

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.